Chandan K. Saha
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Research Subjects
Chandan K. Saha has a total of 8 co-authors. Here are the top co-authors by number of shared publications:
- Jay H. Shubrook
College of Osteopathic Medicine, Touro University California, Vallejo, CA
1 shared publication - Kent A. Crick
Counseling and Psychological Services, University of California Los Angeles, Los Angeles, CA 90095, USA
1 shared publication - Kieren J. Mather
Eli Lilly and Company Indianapolis Indiana USA
1 shared publication - Mary de Groot
Indiana University School of Medicine, Indianapolis, IN
1 shared publication Michael P. Jones
Department of Biostatistics, University of Iowa, Iowa City, IA, USA
1 shared publication- W. Guyton Jr Hornsby
Department of Exercise Physiology, West Virginia University, Morgantown, WV 26506, USA
1 shared publication
Latest Publications
- Open Access
- 22 July 2025
- Published by MDPI AG in Healthcare
- Vol. 13 (15) , 1773
A Post-Hoc Analysis of Depressive Disorders in Patients with Type 2 Diabetes
Background/Objectives: This study is an investigation of the occurrence, remission and recurrence of major depressive disorders (MDDs) in adults with type 2 diabetes (T2DM). Methods: Interviews were conducted with individuals (N = 176) who met the criteria for MDD using the Structured Clinical Interview for the DSM-IV-TR (SCID). Results: N = 176 T2DM adults, with a mean (SD) age of 55.5 (10.4) years, 74% of whom were female and 62% were white, completed the Structured Clinical Interview for the DSM-IV-TR (SCID). A mean (SD) number of 1.8 (0.9) episodes of major depression (MDD) were recorded from birth to the date of interview, with a mean (SD) onset age of the first episode of 40.4 (15.9) years. Median (IQR) MDD episode duration was 13.9 (5.6–31.9) months and the median (IQR) cumulative lifetime exposure duration to MDD was 33 (12.9–63.1) months. Kaplan–Meier survival analysis along with the frailty model, to account for the correlation among multiple recurrences or remissions within a subject, indicated that the median first episode duration was shorter than the median second episode duration (14 vs. 37.9 months, p < 0.0001). Of those who had at least three episodes, the median second episode duration was shorter than the median third-episode duration (13.0 vs. 28.0 months, p = 0.006). The median recurrence time following first remission was significantly longer than the median recurrence time following second remission (138.0 vs. 80.6 months, p = 0.02). Conclusions: These results document that clinical depression is recurrent in adults with T2DM. Moreover, depressive episodes in individuals with T2DM are persistent well beyond episode durations observed in the general population.
- 22 July 2025
- Published by MDPI AG in Healthcare
- Vol. 13 (15) , 1773
Open AccessA Post-Hoc Analysis of Depressive Disorders in Patients with Type 2 Diabetes
Background/Objectives: This study is an investigation of the occurrence, remission and recurrence of major depressive disorders (MDDs) in adults with type 2 diabetes (T2DM). Methods: Interviews were conducted with individuals (N = 176) who met the criteria for MDD using the Structured Clinical Interview for the DSM-IV-TR (SCID). Results: N = 176 T2DM adults, with a mean (SD) age of 55.5 (10.4) years, 74% of whom were female and 62% were white, completed the Structured Clinical Interview for the DSM-IV-TR (SCID). A mean (SD) number of 1.8 (0.9) episodes of major depression (MDD) were recorded from birth to the date of interview, with a mean (SD) onset age of the first episode of 40.4 (15.9) years. Median (IQR) MDD episode duration was 13.9 (5.6–31.9) months and the median (IQR) cumulative lifetime exposure duration to MDD was 33 (12.9–63.1) months. Kaplan–Meier survival analysis along with the frailty model, to account for the correlation among multiple recurrences or remissions within a subject, indicated that the median first episode duration was shorter than the median second episode duration (14 vs. 37.9 months, p < 0.0001). Of those who had at least three episodes, the median second episode duration was shorter than the median third-episode duration (13.0 vs. 28.0 months, p = 0.006). The median recurrence time following first remission was significantly longer than the median recurrence time following second remission (138.0 vs. 80.6 months, p = 0.02). Conclusions: These results document that clinical depression is recurrent in adults with T2DM. Moreover, depressive episodes in individuals with T2DM are persistent well beyond episode durations observed in the general population.
- Open Access
- 4 August 2015
- Published by Taylor & Francis in Journal of Applied Statistics
- Vol. 43 (2) , 1-15
Type I and Type II error rates in the last observation carried forward method under informative dropout
Dropout is a persistent problem for a longitudinal study. We exhibit the shortcomings of the last observation carried forward method. It produces biased estimates of change in an outcome from baseline to study endpoint under informative dropout. We developed a theoretical quantification of the effect of such bias on type I and type II error rates. We present results for a setup where a subject either completes the study or drops out during one particular interval, and also under the setup in which subjects could drop out at any time during the study. The type I error rate steadily increases when time to dropout decreases or the common sample size increases. The inflation in type I error rate can be substantially high when reasons for dropout in the two groups differ; when there is a large difference in dropout rates between the control and treatment groups and when the common sample size is large; even when dropout subjects have one or two fewer observations than the completers. Similar results are also observed for type II error rates. A study can have very low power when early recovered patients in the treatment group and worsening patients in the control group drop out even near the end of the study.
- 4 August 2015
- Published by Taylor & Francis in Journal of Applied Statistics
- Vol. 43 (2) , 1-15
Open AccessType I and Type II error rates in the last observation carried forward method under informative dropout
Dropout is a persistent problem for a longitudinal study. We exhibit the shortcomings of the last observation carried forward method. It produces biased estimates of change in an outcome from baseline to study endpoint under informative dropout. We developed a theoretical quantification of the effect of such bias on type I and type II error rates. We present results for a setup where a subject either completes the study or drops out during one particular interval, and also under the setup in which subjects could drop out at any time during the study. The type I error rate steadily increases when time to dropout decreases or the common sample size increases. The inflation in type I error rate can be substantially high when reasons for dropout in the two groups differ; when there is a large difference in dropout rates between the control and treatment groups and when the common sample size is large; even when dropout subjects have one or two fewer observations than the completers. Similar results are also observed for type II error rates. A study can have very low power when early recovered patients in the treatment group and worsening patients in the control group drop out even near the end of the study.